Sierra Oncology Inc
NASDAQ:SRRA
Income Statement
Earnings Waterfall
Sierra Oncology Inc
Revenue
|
0
USD
|
Operating Expenses
|
-102.6m
USD
|
Operating Income
|
-102.6m
USD
|
Other Expenses
|
-40k
USD
|
Net Income
|
-102.7m
USD
|
Income Statement
Sierra Oncology Inc
Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+200%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | |||||||||||||||||||||||||||||||
Operating Expenses |
(23)
|
(27)
|
(20)
|
(28)
|
(36)
|
(40)
|
(46)
|
(50)
|
(48)
|
(49)
|
(46)
|
(41)
|
(43)
|
(43)
|
(46)
|
(52)
|
(55)
|
(57)
|
(59)
|
(57)
|
(67)
|
(70)
|
(71)
|
(72)
|
(65)
|
(69)
|
(73)
|
(87)
|
(95)
|
(103)
|
|
Selling, General & Administrative |
(3)
|
(4)
|
(6)
|
(7)
|
(9)
|
(12)
|
(14)
|
(14)
|
(14)
|
(13)
|
(13)
|
(13)
|
(12)
|
(13)
|
(14)
|
(14)
|
(14)
|
(14)
|
(14)
|
(14)
|
(14)
|
(15)
|
(18)
|
(19)
|
(20)
|
(21)
|
(22)
|
(24)
|
(27)
|
(32)
|
|
Research & Development |
(19)
|
(23)
|
(15)
|
(20)
|
(26)
|
(28)
|
(32)
|
(36)
|
(34)
|
(35)
|
(33)
|
(28)
|
(30)
|
(30)
|
(32)
|
(38)
|
(41)
|
(43)
|
(46)
|
(43)
|
(53)
|
(55)
|
(53)
|
(53)
|
(45)
|
(47)
|
(51)
|
(63)
|
(67)
|
(71)
|
|
Operating Income |
(23)
N/A
|
(27)
-20%
|
(20)
+26%
|
(28)
-38%
|
(36)
-30%
|
(40)
-11%
|
(46)
-16%
|
(50)
-9%
|
(48)
+4%
|
(49)
-1%
|
(46)
+5%
|
(41)
+11%
|
(43)
-4%
|
(43)
-1%
|
(46)
-6%
|
(52)
-13%
|
(55)
-7%
|
(57)
-3%
|
(59)
-4%
|
(57)
+5%
|
(67)
-18%
|
(70)
-4%
|
(71)
-2%
|
(72)
-2%
|
(65)
+10%
|
(69)
-6%
|
(73)
-6%
|
(87)
-19%
|
(95)
-9%
|
(103)
-9%
|
|
Pre-Tax Income | |||||||||||||||||||||||||||||||
Interest Income Expense |
(1)
|
(3)
|
(11)
|
(18)
|
(17)
|
(16)
|
(7)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(21)
|
(37)
|
(37)
|
(37)
|
(16)
|
0
|
0
|
0
|
0
|
(0)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
1
|
(1)
|
(0)
|
(1)
|
(1)
|
0
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
|
Pre-Tax Income |
(24)
N/A
|
(29)
-23%
|
(31)
-5%
|
(45)
-47%
|
(53)
-17%
|
(56)
-5%
|
(53)
+4%
|
(50)
+6%
|
(48)
+5%
|
(48)
-1%
|
(46)
+5%
|
(40)
+11%
|
(42)
-3%
|
(42)
-1%
|
(44)
-5%
|
(50)
-13%
|
(54)
-7%
|
(55)
-3%
|
(58)
-4%
|
(55)
+4%
|
(88)
-60%
|
(107)
-21%
|
(109)
-2%
|
(110)
-1%
|
(81)
+27%
|
(69)
+15%
|
(73)
-6%
|
(87)
-19%
|
(95)
-9%
|
(103)
-9%
|
|
Net Income | |||||||||||||||||||||||||||||||
Tax Provision |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
7
|
7
|
7
|
8
|
0
|
1
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
|
Income from Continuing Operations |
(24)
|
(29)
|
(31)
|
(45)
|
(53)
|
(56)
|
(53)
|
(50)
|
(48)
|
(48)
|
(46)
|
(41)
|
(35)
|
(35)
|
(37)
|
(42)
|
(53)
|
(55)
|
(58)
|
(55)
|
(88)
|
(107)
|
(109)
|
(110)
|
(81)
|
(69)
|
(73)
|
(87)
|
(95)
|
(103)
|
|
Net Income (Common) |
(24)
N/A
|
(29)
-23%
|
(31)
-5%
|
(45)
-47%
|
(53)
-17%
|
(56)
-5%
|
(53)
+4%
|
(50)
+6%
|
(48)
+4%
|
(48)
-1%
|
(46)
+5%
|
(41)
+11%
|
(42)
-3%
|
(42)
-1%
|
(44)
-4%
|
(50)
-13%
|
(53)
-7%
|
(55)
-3%
|
(58)
-5%
|
(55)
+5%
|
(88)
-60%
|
(107)
-21%
|
(109)
-1%
|
(110)
-1%
|
(81)
+27%
|
(69)
+15%
|
(73)
-6%
|
(87)
-19%
|
(95)
-9%
|
(103)
-8%
|
|
EPS (Diluted) |
-6.56
N/A
|
-8.27
-26%
|
-772
-9 235%
|
-75.72
+90%
|
-71.03
+6%
|
-74.35
-5%
|
-71.17
+4%
|
-65.89
+7%
|
-62.99
+4%
|
-45.68
+27%
|
-35.02
+23%
|
-31.05
+11%
|
-32.08
-3%
|
-28.5
+11%
|
-23.7
+17%
|
-26.7
-13%
|
-28.68
-7%
|
-29.48
-3%
|
-30.89
-5%
|
-29.46
+5%
|
-14.57
+51%
|
-10.55
+28%
|
-10.45
+1%
|
-10.57
-1%
|
-7.33
+31%
|
-5.9
+20%
|
-5.92
0%
|
-6.38
-8%
|
-6.19
+3%
|
-4.9
+21%
|